Boyd Watterson Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Buy
3,790
+19
+0.5% +$10.3K 0.57% 45
2025
Q4
$2.19M Buy
3,771
+28
+0.7% +$15.8K 0.63% 42
2025
Q3
$1.82M Sell
3,743
-483
-11% -$225K 0.54% 46
2025
Q2
$1.71M Sell
4,226
-10
-0.2% -$4.18K 0.54% 48
2025
Q1
$2.11M Sell
4,236
-20
-0.5% -$10.8K 0.67% 44
2024
Q4
$2.21M Sell
4,256
-6
-0.1% -$3.3K 0.62% 44
2024
Q3
$2.64M Sell
4,262
-6
-0.1% -$3.55K 0.72% 35
2024
Q2
$2.36M Hold
4,268
0.67% 36
2024
Q1
$2.48M Buy
4,268
+49
+1% +$27.5K 0.89% 33
2023
Q4
$2.24M Sell
4,219
-8
-0.2% -$3.87K 0.88% 31
2023
Q3
$2.14M Sell
4,227
-5
-0.1% -$2.66K 0.94% 30
2023
Q2
$2.21M Sell
4,232
-2
-0% -$1.08K 0.88% 31
2023
Q1
$2.44M Sell
4,234
-20
-0.5% -$11.3K 0.99% 29
2022
Q4
$2.34M Sell
4,254
-6
-0.1% -$3.18K 0.97% 29
2022
Q3
$2.16M Buy
4,260
+15
+0.4% +$8.39K 0.98% 29
2022
Q2
$2.31M Sell
4,245
-75
-2% -$41.3K 0.98% 28
2022
Q1
$2.55M Hold
4,320
0.93% 32
2021
Q4
$2.88M Sell
4,320
-15
-0.3% -$9.37K 0.96% 33
2021
Q3
$2.48M Buy
4,335
+1
+0% +$549 0.91% 33
2021
Q2
$2.19M Buy
4,334
+10
+0.2% +$4.72K 0.88% 37
2021
Q1
$1.97M Buy
4,324
+92
+2% +$43.9K 0.86% 34
2020
Q4
$1.97M Buy
4,232
+70
+2% +$32.8K 0.94% 31
2020
Q3
$1.84M Buy
4,162
+2,486
+148% +$1.03M 1.01% 29
2020
Q2
$607K Hold
1,676
0.41% 71
2020
Q1
$475K Sell
1,676
-679
-29% -$214K 0.39% 74
2019
Q4
$765K Buy
2,355
+447
+23% +$136K 0.5% 66
2019
Q3
$556K Sell
1,908
-303
-14% -$86.8K 0.39% 74
2019
Q2
$649K Buy
2,211
+12
+0.5% +$3.31K 0.44% 69
2019
Q1
$602K Hold
2,199
0.38% 76
2018
Q4
$492K Buy
2,199
+158
+8% +$37.1K 0.36% 79
2018
Q3
$498K Hold
2,041
0.28% 86
2018
Q2
$423K Buy
2,041
+117
+6% +$24.8K 0.24% 91
2018
Q1
$397K Buy
1,924
+532
+38% +$112K 0.2% 111
2017
Q4
$264K Buy
+1,392
New +$267K 0.13% 133

Other funds holding TMO